Biosimilars Switching Policies in Canada

Published date17 May 2021
Subject MatterPrescription Drugs,Biosimilars,Canada,Health Canada
Law FirmGoodwin

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT